Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140559

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease: Medical Records
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a patient registry on Kawasaki disease.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	279383
	answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>No such assessment has been made.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:41:26 answering member 4455 label Biography information for Seema Kennedy previous answer version 131091 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1400 label Biography information for Kevin Brennan

1140557

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of (a) the potential cost savings of improving early identification and treatment of Kawasaki disease and (b) the potential consequent reduction in demand for long-term specialist care for children with that disease.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	279381
	answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The requested information is not available and therefore no such estimate has been made.</p><p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:40:10 answering member 4455 label Biography information for Seema Kennedy previous answer version 131089 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1400 label Biography information for Kevin Brennan

1140558

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what support his Department is providing to (a) enable early treatment and (b) increase awareness amongst healthcare providers of Kawasaki disease .
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	279382
	answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:37:42 answering member 4455 label Biography information for Seema Kennedy previous answer version 131090 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1400 label Biography information for Kevin Brennan

1355884

	registered interest
	date	15/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Parliamentary and Health Service Ombudsman
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the need for additional resources to help ensure that NHS bodies provide timely responses to requests for information to assist investigations by the Parliamentary and Health Service Ombudsman.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	49963
	answer	answer is ministerial correction date of answer 23/09/2021 answer text <p>We have made no such assessment.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 23/09/2021 13:27:38 answering member 4492 label Biography information for Maria Caulfield previous answer version 22507 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
	tabling member	1400 label Biography information for Kevin Brennan

1343069

	registered interest
	date	01/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many items of written correspondence from hon. Members sent to Ministers in his Department have been (a) received and (b) replied to since 1 April 2020; and how many of those responses were responded to by (i) Ministers and (ii) officials.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	25741
	answer	answer is ministerial correction date of answer 08/07/2021 answer text <p>Between 1 April 2020 and 31 June 2021, the Department received 44,456 items of written correspondence from hon. Members, of which 37,527 have received a reply.</p><p>The information requested on the number of responses from Minister and officials is not collected centrally and could only be obtained at disproportionate cost.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/07/2021 12:25:47 answering member 4362 label Biography information for Edward Argar previous answer version 12071 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
	tabling member	1400 label Biography information for Kevin Brennan

1140560

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent comparative assessment he has made of the UK level of research funding into Kawasaki disease with that of other EU member states.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	279384
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The Department has not made a recent comparative assessment of the United Kingdom level of research funding into Kawasaki disease with that of other European Union member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease study led from Great Ormond Street Hospital/University College London. The trial, which aims to recruit 262 children from 40 centres across Europe, will look at the effectiveness of using of steroids in addition to the standard treatment for Kawasaki syndrome, intravenous immunoglobulins. The award is for over €5 million in funding for the trial to be run through a new European consortium, connect4children.</p><p> </p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:19:10 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 131092 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1400 label Biography information for Kevin Brennan

1060643

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	220816
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.</p><p> </p><p>The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom’s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.</p><p> </p><p>As a responsible Government, we are planning for all possible exit scenarios, including ‘no deal’. Our ‘no deal’ medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.</p><p> </p><p>On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a ‘no deal’ EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.</p><p> </p><p>We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:10:21 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1400 label Biography information for Kevin Brennan

1051440

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	214517
	answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Guidance is available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p> </p><p>Information about the symptoms, causes, diagnosis, treatment and complications of Kawasaki disease is also available on the National Health Service website.</p><p> </p><p>Furthermore, learning information and resources for clinicians about Kawasaki disease is available from Societi, The UK Kawasaki Disease Foundation. Societi engages with a range of NHS stakeholders to raise awareness of Kawasaki disease, and has a number of senior clinicians on its Scientific Advisory Board who work in leading NHS institutions and who have expertise in relevant clinical areas such as vasculitis and paediatric cardiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:22:23 answering member 4067 label Biography information for Steve Brine
	tabling member	1400 label Biography information for Kevin Brennan

1029493

	registered interest
	date	20/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Infant Mortality
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase support for families who have suffered baby loss.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	204429
	answer	answer is ministerial correction date of answer 07/01/2019 answer text <p>The Government is working to improve the care and support received by families who experience baby loss. The Department has provided funding to Sands, the stillbirth and neonatal death charity, to work with other baby loss charities and Royal Colleges to produce the National Bereavement Care Pathway (NBCP) to reduce the variation in the quality of bereavement care provided by the National Health Service.</p><p> </p><p>The NBCP helps professionals to support families in their bereavement after any pregnancy or baby loss, be that miscarriage (including ectopic and molar pregnancy), termination of pregnancy for fetal anomaly, stillbirth, neonatal death or sudden unexpected death in infancy. In October 2018, all of the NBCP guidance materials and tools were published online.</p><p> </p><p>In addition, NHS England’s Perinatal Mental Health Team has been working with Sands to ensure that the NBCP guidelines effectively signpost universal mental health screening and referral to evidence-based interventions and support.</p><p> </p><p>Furthermore, the Pregnancy Loss Review which the Department commissioned earlier this year, has been considering the question of whether legislation should provide new rights to bereaved parents to register pregnancy loss occurring before 24 weeks gestation, as well as investigating the impact of such losses on families and how care can be improved for parents who experience this. The review has been widely consulting with parents, charities and medical professionals and is currently scheduled to be completed in early 2019.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/01/2019 15:16:42 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	1400 label Biography information for Kevin Brennan

1064722

	registered interest
	date	21/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Reciprocal Arrangements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many times European Health Insurance Cards were used by UK citizens abroad in the past year.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	224302
	answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>There were 118,684 accepted claims when a European Health Insurance Card (EHIC) was used, in the last 12 months.</p><p> </p><p>There are 3,108,739 United Kingdom-issued EHICs in circulation for people aged over 70. This is based on cards which have not expired and the applicant’s age on the date the card was issued, and not their current age. EHICs are valid for five years after their issue date.</p><p> </p><p>Information is not available on the number of times EHICs were used by UK citizens abroad to support the treatment of pre-existing conditions in the last year.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224304 224305 question first answered 26/02/2019 16:23:35 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1400 label Biography information for Kevin Brennan